Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03438396
Title A Trial of Tisotumab Vedotin in Cervical Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genmab
Indications

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma

Therapies

Tisotumab vedotin-tftv

Age Groups: senior | adult
Covered Countries USA | ITA | ESP | DEU | BEL


No variant requirements are available.